| Literature DB >> 32614888 |
Zhao Chen1, Dai Kuang2, Xuebin Xu3, Narjol González-Escalona4, David L Erickson1, Eric Brown4, Jianghong Meng1.
Abstract
We sequenced 25 isolates of phenotypically multidrug-resistant Salmonella Indiana (n = 11), Typhimurium (n = 8), and Enteritidis (n = 6) using both MinION long-read [SQK-LSK109 and flow cell (R9.4.1)] and MiSeq short-read (Nextera XT and MiSeq Reagent Kit v2) sequencing technologies to determine the advantages of each approach in terms of the characteristics of genome structure, antimicrobial resistance (AMR), virulence potential, whole-genome phylogeny, and pan-genome. The MinION reads were base-called in real-time using MinKnow 3.4.8 integrated with Guppy 3.0.7. The long-read-only assembly, Illumina-only assembly, and hybrid assembly pipelines of Unicycler 0.4.8 were used to generate the MinION, MiSeq, and hybrid assemblies, respectively. The MinION assemblies were highly contiguous compared to the MiSeq assemblies but lacked accuracy, a deficiency that was mitigated by adding the MiSeq short reads through the Unicycler hybrid assembly which corrected erroneous single nucleotide polymorphisms (SNPs). The MinION assemblies provided similar predictions of AMR and virulence potential compared to the MiSeq and hybrid assemblies, although they produced more total false negatives of AMR genotypes, primarily due to failure in identifying tetracycline resistance genes in 11 of the 19 MinION assemblies of tetracycline-resistant isolates. The MinION assemblies displayed a large genetic distance from their corresponding MiSeq and hybrid assemblies on the whole-genome phylogenetic tree, indicating that the lower read accuracy of MinION sequencing caused incorrect clustering. The pan-genome of the MinION assemblies contained significantly more accessory genes and less core genes compared to the MiSeq and hybrid assemblies, suggesting that although these assemblies were more contiguous, their sequencing errors reduced accurate genome annotations. Our research demonstrates that MinION sequencing by itself provides an efficient assessment of the genome structure, antimicrobial resistance, and virulence potential of Salmonella; however, it is not sufficient for whole-genome phylogenetic and pan-genome analyses. MinION in combination with MiSeq facilitated the most accurate genomic analyses.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32614888 PMCID: PMC7332006 DOI: 10.1371/journal.pone.0235641
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The hybrid, MinION, and MiSeq assemblies of Salmonella isolates.
| Serotype | Isolate ID | Source | Number of contigs | Total length (bp) | GC content (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hybrid | MinION | MiSeq | Hybrid | MinION | MiSeq | Hybrid | MinION | MiSeq | |||
| Indiana | 43 | Seafood | 1 | 1 | 114 | 4,993,824 | 4,984,753 | 4,936,551 | 51.80 | 51.93 | 51.76 |
| 67 | Chicken | 2 | 2 | 105 | 5,072,601 | 5,060,699 | 5,020,783 | 51.79 | 51.90 | 51.75 | |
| 85 | Chicken | 4 | 4 | 132 | 4,991,315 | 5,060,699 | 4,932,554 | 51.91 | 51.90 | 51.87 | |
| 96 | Human | 2 | 2 | 107 | 4,973,668 | 4,962,533 | 4,935,343 | 51.86 | 51.98 | 51.81 | |
| 102 | Human | 6 | 3 | 99 | 4,985,118 | 4,962,779 | 4,922,609 | 51.89 | 52.04 | 51.85 | |
| 108 | Human | 2 | 2 | 131 | 5,071,476 | 5,061,911 | 4,993,042 | 52.01 | 52.14 | 51.97 | |
| 111 | Human | 5 | 2 | 146 | 4,899,773 | 4,873,314 | 4,826,124 | 52.01 | 52.14 | 52.00 | |
| 115 | Human | 2 | 2 | 86 | 4,974,921 | 4,957,216 | 4,919,970 | 51.85 | 51.98 | 51.81 | |
| 170 | Human | 2 | 2 | 110 | 5,028,741 | 5,015,229 | 4,971,399 | 51.80 | 51.91 | 51.76 | |
| 173 | Pork | 3 | 3 | 102 | 4,838,602 | 4,887,971 | 4,832,973 | 52.07 | 52.18 | 52.06 | |
| 174 | Beef | 1 | 1 | 166 | 4,929,169 | 4,918,265 | 4,858,029 | 51.95 | 52.06 | 51.93 | |
| Typhimurium | 45 | Human | 3 | 4 | 105 | 5,259,999 | 5,287,617 | 5,205,240 | 51.94 | 52.07 | 51.90 |
| 46 | Human | 3 | 3 | 125 | 5,259,220 | 5,244,083 | 5,206,196 | 51.95 | 52.09 | 51.91 | |
| 53 | Human | 4 | 4 | 97 | 5,185,065 | 5,120,128 | 5,123,654 | 52.15 | 52.28 | 52.12 | |
| 56 | Human | 6 | 5 | 141 | 5,210,197 | 5,193,224 | 5,123,456 | 52.24 | 52.34 | 52.18 | |
| 90 | Duck | 5 | 5 | 130 | 5,177,998 | 5,165,774 | 5,103,046 | 52.22 | 52.37 | 52.18 | |
| 101 | Human | 3 | 3 | 166 | 5,225,110 | 5,255,160 | 5,099,151 | 52.15 | 52.28 | 52.09 | |
| 106 | Human | 3 | 3 | 90 | 5,195,418 | 5,184,502 | 5,147,440 | 51.86 | 51.95 | 51.83 | |
| 113 | Human | 2 | 2 | 119 | 5,121,995 | 5,110,567 | 5,071,774 | 52.18 | 52.31 | 52.15 | |
| Enteritidis | 74 | Human | 3 | 3 | 71 | 4,859,063 | 4,848,928 | 4,826,041 | 52.15 | 52.25 | 52.12 |
| 81 | Human | 2 | 3 | 44 | 4,797,988 | 4,828,175 | 4,761,547 | 52.16 | 52.25 | 52.13 | |
| 95 | Human | 5 | 4 | 99 | 4,839,384 | 4,828,999 | 4,816,051 | 52.18 | 52.28 | 52.14 | |
| 104 | Human | 4 | 4 | 67 | 4,848,540 | 4,839,326 | 4,811,720 | 52.19 | 52.29 | 52.15 | |
| 109 | Human | 3 | 3 | 72 | 4,829,486 | 4,820,259 | 4,801,197 | 52.17 | 52.27 | 52.15 | |
| 124 | Chicken | 3 | 3 | 57 | 4,847,360 | 4,835,849 | 4,806,481 | 52.19 | 52.29 | 52.16 | |
aAll contigs of the hybrid and MinION assemblies were circularized. The hybrid and MinION assemblies that had more than one contigs contained one chromosome and one or more plasmids.
Fig 1Bioinformatic workflow of the hybrid, MinION, and MiSeq assemblies.
Fig 2Circular chromosome map of S. Indiana isolate 43 (SI43H) based on its hybrid assembly.
Antimicrobial resistance (AMR) phenotypes of S. Indiana isolates, and their corresponding AMR genotypes, as predicted based on their hybrid, MinION, and MiSeq assemblies.
| Antibiotic class | Phenotype vs genotype | Method | Isolate ID | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43 | 67 | 85 | 96 | 102 | 108 | 111 | 115 | 170 | 173 | 174 | |||
| Phenotype | AST | AMP | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | AMP | AMP, AMC, EFT, CEP, CRO | AMP, AMC, EFT, CEP, CRO | AMP, EFT, CEP, CRO | - | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | |
| Genotype | Hybrid | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | - | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | |
| MinION | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | - | AMP, AMC, EFT, CEP, CRO, FOX, STR | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | ||
| MiSeq | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | - | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | ||
| Aminoglycoside | Phenotype | AST | AMK, GEN, KAN, STR | GEN, KAN | AMK, GEN, KAN, STR | STR | GEN, KAN, STR | AMK, GEN, KAN, STR | AMK, GEN, KAN, STR | STR | GEN, KAN | GEN, KAN | - |
| Genotype | Hybrid | AMK, GEN, KAN, STR, HYB | AMK, GEN, STR, HYB | AMK, GEN, KAN, STR, HYB | AMK, KAN, STR | AMK, GEN, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | AMK, KAN, STR | KAN, STR | AMK, GEN, STR, HYB | AMK, KAN | AMK, GEN, KAN, STR, HYB | |
| MinION | AMK, GEN, KAN, STR, HYB | AMK, GEN, STR, HYB | AMK, GEN, KAN, STR, HYB | AMK, KAN, STR | AMK, GEN, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | AMK, KAN, STR | KAN, STR | AMK, GEN | AMK, GEN, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | ||
| MiSeq | AMK, GEN, KAN, STR, HYB | AMK, GEN, STR, HYB | AMK, GEN, KAN, STR, HYB | AMK, KAN, STR | AMK, GEN, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | AMK, KAN, STR | KAN, STR | AMK, GEN, STR, HYB | AMK, GEN, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | ||
| Tetracycline | Phenotype | AST | TET | TET | - | TET | TET | TET | - | TET | TET | TET | TET |
| Genotype | Hybrid | TET | TET | TET | TET | TET | TET | - | TET | TET | - | TET | |
| MinION | - | - | - | TET | - | - | - | TET | TET | - | TET | ||
| MiSeq | TET | TET | TET | TET | TET | TET | - | TET | TET | TET | TET | ||
| Sulfonamide and trimethoprim | Phenotype | AST | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL, SXT | SUL |
| Genotype | Hybrid | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL, SXT | SUL, SXT | |
| MinION | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL | SUL, SXT | SUL | SUL, SXT | SUL, SXT | SUL, SXT | ||
| MiSeq | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL, SXT | SUL, SXT | ||
| Others not tested in AST | Genotype | Hybrid | FOS, RIF, QAC | BLM, QAC | BLM, MAC, RIF, QAC | RIF, MAC, QAC | RIF, BLM, QAC | RIF, MAC, QAC | BLM, FOS, MAC, RIF, QAC | BLM, MAC | BLM, FOS, QAC | BLM, QAC | QAC |
| MinION | FOS, RIF, QAC, CST | BLM, QAC, CST | MAC, RIF, QAC, CST | RIF, MAC, QAC, CST | RIF, BLM, MAC, QAC | RIF, QAC | MAC, RIF, QAC, CST | BLM, CST | BLM, FOS, QAC, CST | BLM, QAC | QAC, CST | ||
| MiSeq | FOS, RIF, QAC | BLM, QAC | BLM, MAC, RIF, QAC | RIF, MAC, QAC | RIF, BLM | RIF, MAC, QAC | BLM, FOS, MAC, RIF, QAC | BLM, MAC | BLM, FOS, QAC | BLM, QAC | QAC | ||
aAMP, ampicillin; AMC, amoxicillin/clavulanic acid; EFT, ceftiofur; CEP, cefalexin; CRO, ceftriaxone; FOX, cefoxitin; CHL, chloramphenicol; NAL, nalidixic acid; CIP, ciprofloxacin; LVX, levofloxacin; OFX, ofloxacin; AMK, amikacin; GEN, gentamicin; KAN, kanamycin; STR, streptomycin; HYB, hygromycin; TET, tetracycline; SUL, sulfafurazole; SXT, sulfamethoxazole/trimethoprim; BLM, bleomycin; FOS, fosfomycin; MAC, macrolide; RIF, rifamycin; QAC, quaternary ammonium compounds; CST, colistin.
b not detected.
cFor the antibiotic class of phenicol, isolates 67, 85, 102, 108, 170, 173, and 174 were phenotypically resistant to CHL. For the antibiotic class of quinolone, all isolates were phenotypically resistant to NAL, CIP, LVX, and OFX. The phenotypes of the antibiotic classes of phenicol and quinolone for all isolates were consistent with their genotypes, as predicted based on their hybrid, MinION, and MiSeq assemblies.
Antimicrobial resistance (AMR) phenotypes of S. Enteritidis isolates, and their corresponding AMR genotypes, as predicted based on their hybrid, MinION, and MiSeq assemblies.
| Antibiotic class | Phenotype vs genotype | Method | Isolate ID | |||||
|---|---|---|---|---|---|---|---|---|
| 74 | 81 | 95 | 104 | 109 | 124 | |||
| Phenotype | AST | AMP | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | |
| Genotype | Hybrid | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | |
| MinION | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | ||
| MiSeq | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | ||
| Phenicol | Phenotype | AST | - | - | - | - | - | CHL |
| Genotype | Hybrid | CHL | - | CHL | CHL | CHL | CHL | |
| MinION | - | - | CHL | CHL | CHL | CHL | ||
| MiSeq | CHL | - | CHL | CHL | CHL | CHL | ||
| Quinolone | Phenotype | AST | NAL | NAL | NAL | NAL | NAL | NAL |
| Aminoglycoside | Phenotype | AST | KAN | - | GEN, KAN | KAN, STR | KAN | KAN, STR |
| Genotype | Hybrid | KAN | - | GEN, KAN | KAN, STR | KAN | KAN, STR | |
| MinION | KAN | - | GEN, KAN | KAN, STR | KAN | KAN, STR | ||
| MiSeq | KAN | - | GEN, KAN | KAN, STR | KAN | KAN, STR | ||
| Tetracycline | Phenotype | AST | - | - | - | TET | - | TET |
| Genotype | Hybrid | - | - | - | TET | - | TET | |
| MinION | - | - | - | - | - | TET | ||
| MiSeq | - | - | - | TET | - | TET | ||
| Others not tested in AST | Genotype | Hybrid | BLM | - | BLM | BLM, FOS | BLM | BLM |
| MinION | BLM | - | BLM | BLM, FOS, CST | CST | - | ||
| MiSeq | BLM | - | BLM | BLM, FOS | BLM | BLM | ||
aAMP, ampicillin; AMC, amoxicillin/clavulanic acid; EFT, ceftiofur; CEP, cefalexin; CRO, ceftriaxone; FOX, cefoxitin; CHL, chloramphenicol; NAL, nalidixic acid; CIP, ciprofloxacin; LVX, levofloxacin; OFX, ofloxacin; AMK, amikacin; GEN, gentamicin; KAN, kanamycin; STR, streptomycin; HYB, hygromycin; TET, tetracycline; SUL, sulfafurazole; SXT, sulfamethoxazole/trimethoprim; BLM, bleomycin; FOS, fosfomycin; MAC, macrolide; RIF, rifamycin; QAC, quaternary ammonium compounds; CST, colistin.
b-, not detected.
cFor the antibiotic class of quinolone, all isolates were genotypically resistant to NAL, CIP, LVX, and OFX. For the antibiotic class of sulfonamide and trimethoprim, isolates 104 and 124 were phenotypically resistant to SUL, which was consistent with their genotypes, as predicted based on their hybrid, MinION, and MiSeq assemblies.
Numbers of false positives and false negatives of antimicrobial resistance (AMR) genotypes of Salmonella isolates for each antibiotic, as predicted based on their hybrid, MinION, and MiSeq assemblies.
| Antibiotic class | Antibiotic | False positives | False negatives | ||||
|---|---|---|---|---|---|---|---|
| Hybrid | MinION | MiSeq | Hybrid | MinION | MiSeq | ||
| AMP | 0 | 0 | 0 | 12 | 4 | 12 | |
| AMC | 9 | 16 | 7 | 1 | 0 | 0 | |
| EFT | 2 | 2 | 2 | 0 | 0 | 0 | |
| CEP | 2 | 2 | 2 | 0 | 0 | 0 | |
| CRO | 2 | 2 | 2 | 0 | 0 | 0 | |
| FOX | 23 | 23 | 23 | 0 | 0 | 0 | |
| Phenicol | CHL | 4 | 3 | 4 | 0 | 0 | 0 |
| Quinolone | NAL | 0 | 0 | 0 | 0 | 1 | 0 |
| CIP | 7 | 6 | 7 | 0 | 1 | 0 | |
| LVX | 9 | 8 | 9 | 0 | 1 | 0 | |
| OFX | 7 | 6 | 7 | 0 | 1 | 0 | |
| Aminoglycoside | AMK | 11 | 10 | 11 | 0 | 0 | 0 |
| GEN | 1 | 1 | 1 | 2 | 4 | 1 | |
| KAN | 5 | 5 | 5 | 2 | 3 | 2 | |
| STR | 4 | 4 | 5 | 0 | 0 | 0 | |
| Tetracycline | TET | 1 | 0 | 1 | 1 | 11 | 0 |
| Sulfonamide and trimethoprim | SUL | 0 | 0 | 0 | 0 | 0 | 0 |
| SXT | 2 | 2 | 2 | 0 | 0 | 0 | |
| Total | 89 | 90 | 88 | 18 | 26 | 15 | |
aAMP, ampicillin; AMC, amoxicillin/clavulanic acid; EFT, ceftiofur; CEP, cefalexin; CRO, ceftriaxone; FOX, cefoxitin; CHL, chloramphenicol; NAL, nalidixic acid; CIP, ciprofloxacin; LVX, levofloxacin; OFX, ofloxacin; AMK, amikacin; GEN, gentamicin; KAN, kanamycin; STR, streptomycin; TET, tetracycline; SUL, sulfafurazole; SXT, sulfamethoxazole/trimethoprim.
Numbers of virulence genes and Salmonella pathogenicity islands (SPIs) of Salmonella isolates, as predicted based on their hybrid, MinION, and MiSeq assemblies.
| Serotype | Isolate ID | Number of virulence genes | Number of SPIs | ||||
|---|---|---|---|---|---|---|---|
| Hybrid | MinION | MiSeq | Hybrid | MinION | MiSeq | ||
| Indiana | 43 | 91 | 91 | 91 | 4 | 4 | 5 (SPI-1) |
| 67 | 92 | 92 | 92 | 5 | 5 | 5 | |
| 85 | 91 | 91 | 91 | 5 (SPI-4) | 5 (SPI-4) | 4 | |
| 96 | 91 | 91 | 91 | 5 (SPI-3) | 5 (SPI-3) | 5 (SPI-1) | |
| 102 | 91 | 91 | 91 | 6 | 6 | 6 | |
| 108 | 91 | 91 | 91 | 5 | 6 (SPI-1) | 5 | |
| 111 | 91 | 91 | 91 | 4 | 4 | 5 (SPI-1) | |
| 115 | 91 | 91 | 91 | 5 | 5 | 6 (SPI-1) | |
| 170 | 92 | 92 | 92 | 5 | 6 (SPI-1) | 6 (SPI-1) | |
| 173 | 88 | 88 | 88 | 4 | 4 | 4 | |
| 174 | 93 | 93 | 93 | 5 | 6 (SPI-1) | 6 (SPI-1) | |
| Typhimurium | 45 | 103 | 103 | 103 | 11 (SPI-1, SPI-4) | 11 (SPI-4) | 10 (SPI-1) |
| 46 | 103 | 103 | 103 | 11 (SPI-1, SPI-4) | 11 (SPI-4) | 10 (SPI-1) | |
| 53 | 118 ( | 118 ( | 117 | 11 (SPI-1, SPI-4) | 11 (SPI-4) | 10 (SPI-1) | |
| 56 | 118 | 118 | 118 | 11 (SPI-1, SPI-4) | 11 (SPI-4) | 10 (SPI-1) | |
| 90 | 116 | 116 | 116 | 11 (SPI-1, SPI-4) | 11 (SPI-4) | 10 (SPI-1) | |
| 101 | 103 | 104 | 103 | 12 (SPI-4) | 12 (SPI-4) | 11 | |
| 106 | 103 | 103 | 103 | 11 (SPI-1, SPI-4) | 11 | 10 (SPI-1) | |
| 113 | 103 | 103 | 103 | 11 (SPI-4) | 12 (SPI-4) | 10 | |
| Enteritidis | 74 | 108 | 108 | 108 | 11 (SPI-12) | 11 (SPI-12) | 10 |
| 81 | 108 | 108 | 108 | 11 (SPI-12) | 11 (SPI-12) | 10 | |
| 95 | 107 | 108 ( | 108 ( | 11 (SPI-12) | 11 (SPI-12) | 10 | |
| 104 | 108 | 108 | 108 | 11 (SPI-4, SPI-12) | 11 (SPI-4, SPI-12) | 9 | |
| 109 | 108 | 108 | 108 | 11 (SPI-12) | 11 (SPI-12) | 10 | |
| 124 | 108 | 108 | 108 | 11 (SPI-12) | 11 (SPI-12) | 10 | |
aVirulence genes and SPIs in the parentheses indicate they were detected only by one or two methods.
Fig 3Whole-genome phylogenetic trees of Salmonella isolates based on their hybrid (H), MinION (N), and MiSeq (M) assemblies.
Fig 4Pan-genome compositions (a), and core-genome phylogenetic trees compared to matrices with the presence and absence of core and accessory genes (b) of Salmonella isolates based on their hybrid (A), MinION (B), and MiSeq (C) assemblies.
Antimicrobial resistance (AMR) phenotypes of S. Typhimurium isolates, and their corresponding AMR genotypes, as predicted based on their hybrid, MinION, and MiSeq assemblies.
| Antibiotic class | Phenotype vs genotype | Method | Isolate ID | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 45 | 46 | 53 | 56 | 90 | 101 | 106 | 113 | |||
| Phenotype | AST | AMP | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | AMP, EFT, CEP, CRO | |
| Genotype | Hybrid | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | |
| MinION | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | ||
| MiSeq | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | EFT, CEP, CRO, FOX | AMP, AMC, EFT, CEP, CRO, FOX | ||
| Quinolone | Phenotype | AST | NAL, CIP, OFX | NAL, CIP, OFX | NAL, CIP, LVX, OFX | NAL, CIP, LVX, OFX | NAL, CIP, LVX, OFX | NAL, CIP, LVX, OFX | NAL, CIP, LVX, OFX | - |
| Aminoglycoside | Phenotype | AST | GEN, KAN, STR | GEN, KAN, STR | GEN, KAN, STR | GEN, KAN, STR | AMK, GEN, KAN, STR | GEN, STR | KAN | GEN, STR |
| Genotype | Hybrid | AMK, GEN, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | GEN, KAN, STR | AMK, GEN, KAN, STR | AMK, GEN, KAN, STR | AMK, GEN, KAN, STR | AMK, KAN, STR | GEN, KAN, STR | |
| MinION | AMK, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | KAN, STR | AMK, GEN, KAN, STR | GEN, STR | KAN, STR | AMK, KAN, STR | GEN, KAN, STR | ||
| MiSeq | AMK, GEN, KAN, STR, HYB | AMK, GEN, KAN, STR, HYB | GEN, KAN, STR | AMK, GEN, KAN, STR | AMK, GEN, KAN, STR | AMK, GEN, KAN, STR | AMK, KAN, STR | GEN, KAN, STR | ||
| Tetracycline | Phenotype | AST | TET | TET | TET | TET | TET | TET | TET | TET |
| Genotype | Hybrid | TET | TET | TET | TET | TET | TET | TET | TET | |
| MinION | - | TET | TET | - | - | TET | - | - | ||
| MiSeq | TET | TET | TET | TET | TET | TET | TET | TET | ||
| Sulfonamide and trimethoprim | Phenotype | AST | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL |
| Genotype | Hybrid | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL | |
| MinION | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL | ||
| MiSeq | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL, SXT | SUL | SUL, SXT | SUL | ||
| Others not tested in AST | Genotype | Hybrid | BLM, RIF, QAC | BLM, RIF, QAC | BLM, QAC | MAC, QAC | MAC, QAC | CST | BLM, RIF, QAC | CST |
| MinION | BLM, RIF, QAC, CST | BLM, QAC, CST | QAC | MAC, QAC | QAC | CST | BLM, QAC | CST | ||
| MiSeq | BLM, RIF, QAC | BLM, RIF, QAC | BLM, QAC | MAC, QAC | MAC, QAC | CST | BLM, RIF, QAC | CST | ||
aAMP, ampicillin; AMC, amoxicillin/clavulanic acid; EFT, ceftiofur; CEP, cefalexin; CRO, ceftriaxone; FOX, cefoxitin; CHL, chloramphenicol; NAL, nalidixic acid; CIP, ciprofloxacin; LVX, levofloxacin; OFX, ofloxacin; AMK, amikacin; GEN, gentamicin; KAN, kanamycin; STR, streptomycin; HYB, hygromycin; TET, tetracycline; SUL, sulfafurazole; SXT, sulfamethoxazole/trimethoprim; BLM, bleomycin; FOS, fosfomycin; MAC, macrolide; RIF, rifamycin; QAC, quaternary ammonium compounds; CST, colistin.
b-, not detected.
cFor the antibiotic class of phenicol, all isolates were phenotypically resistant to CHL, which was consistent with their genotypes, as predicted based on their hybrid, MinION, and MiSeq assemblies. For the antibiotic class of quinolone, all isolates were genotypically resistant to NAL, CIP, LVX, and OFX.